- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01412814
Biomechanics of Gait Pattern Adaptation in Patients After Total Knee Arthroplasty
This study aimed to discover the biomechanics of gait pattern adaptation in patients after a total knee replacement.
The first hypothesis of the project was that center-of-pressure manipulation at the foot during dynamic loading is capable of changing the forces, torques and muscle activation patterns of the lower limb.
The second hypothesis of the project was that patient-specific center-of-pressure manipulation at the foot combined with repetitive perturbation training over time will improve neuromuscular function, barefoot gait patterns, muscle activation patterns, pain, quality of life and energy consumption in patients after a total knee replacement.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This study is a randomized prospective controlled study of patients after total knee arthroplasty. Patients will be recruited to the study and divided randomly into an experimental and control group. Both groups will match in terms of gender, age, pathology and clinical assessment. In addition to the intervention of the present study, all patients, whether in the experimental or control group, will carry out the usual physical therapy exercises for total knee arthroplasty as directed by their physician. The patients will be recruited and evaluated prior to surgery and for a follow-up period after surgery.
After surgery, patients in the experimental group will be fitted with a customized biomechanical device worn on the feet (Apos System, Apos - Sports and Medical Technologies Ltd. Hertzlia, Israel). The device is calibrated personally to each patient. By calibrating the device, the center-of-pressure of the foot can be manipulated during all phases of the gait cycle. The device is capable of inducing controlled perturbation during gait. The immediate effects of the device will be evaluated using center-of-pressure measurements, three-dimensional gait analyses and surface electromyography. The patients are instructed to walk with the device according to a therapy protocol (AposTherapy). Patients will be evaluated for changes in gait via three-dimensional gait analyses, muscle activation pattern changes via surface electromyography, pain, quality of life and energy consumption.
The patients in the control group will carry out the same walking exercises as the experimental group, but without the biomechanical intervention device (placebo walking shoe). The patients will be evaluated with the same tools over time as with the experimental group.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Haifa, Israele
- Biorobotics and Biomechanics Lab, Technion Israel Institute of Technology
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patients scheduled for first total knee arthroplasty due to end-stage knee osteoarthritis
- Ambulatory and active patients that can participate in gait analysis
Exclusion Criteria:
- Prior joint surgery of either lower extremity, with the exception of arthroscopy
- Unsteady gait
- Back pain
- Neurological, pulmonary or cardiovascular pathologies or risks that may affect long-term performance
- Inability to understand or comply with the treatment protocol
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Experimental
These patients will carry out the specified intervention of the study with the AposTherapy Biomechanical System in addition to the typical physical therapy regiment prescribed to them by their physician.
|
The device is comprised of four adjustable modular elements attached to foot-worn platforms that are capable of manipulating the foot's center-of-pressure and applying perturbation training throughout the gait cycle.
The device allows for neuromuscular training during dynamic loading.
|
|
Comparatore attivo: Control
The patients within this group will also carry out the typical physical therapy program for total knee replacement as prescribed by their physician.
The patients will carry out a similar therapy program to the experimental group, but without the study intervention device (placebo walking shoe).
|
Their therapy program will be similar to the experimental group, but without the treatment device (placebo walking shoe).
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change from Baseline in Gait Patterns at 6-8 weeks, 5-6 months and 11-12 months
Lasso di tempo: An average of 2 weeks prior to surgery and an average of 6-8 weeks, 5-6 months and 11-12 months after surgery
|
Three-dimensional gait analysis of spatiotemporal, kinetic and kinematic parameters. Surface electromyographic analysis of muscle activation patterns. Center of pressure measurements and function tests. |
An average of 2 weeks prior to surgery and an average of 6-8 weeks, 5-6 months and 11-12 months after surgery
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change from Baseline in Pain, Function and Quality of Life Assessments at 6-8 weeks, 5-6 months and 11-12 months
Lasso di tempo: An average of 2 weeks prior to surgery and an average of 6-8 weeks, 5-6 months and 11-12 months after surgery
|
Includes self-evaluation questionnaires
|
An average of 2 weeks prior to surgery and an average of 6-8 weeks, 5-6 months and 11-12 months after surgery
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- TASMC 11 MS 0569-10-TLV CTIL
- 0569-10-TLV (Identificatore di registro: Institutional Review Board Sourasky Medical Center)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su AposTherapy Biomechanical System
-
HaEmek Medical Center, IsraelCompletato
-
NYU Langone HealthTerminato
-
Apos Medical and Sports Technology Ltd.CompletatoArtrosi al ginocchioSingapore
-
Reciprocal LabsCalifornia HealthCare FoundationCompletato
-
Ahmed AbdullahCompletatoDolore, PostoperatorioPakistan
-
SpineSave AGReclutamentoSpondiloartrite | Instabilità colonna lombare | Spondilolistesi degenerativa | Stenosi spinale lombare degenerativa | Discopatia | Artrosi delle faccette articolariSvizzera
-
Nyra Medical, Inc.Non ancora reclutamentoRigurgito mitralico funzionale
-
Medtronic VascularReclutamentoMalattia cardiovascolare | Malattie vascolari | Ipertensione | Diabete mellito | Malattie renali cronicheOlanda, Belgio, Taiwan, Germania, Australia, Regno Unito, Malaysia, Irlanda
-
Gabi SmartCareCompletatoMalattia cardiovascolare | Malattia respiratoria | Malattia cardiaca | Difetto cardiaco congenito | Malattia infantile prematura | Malattia respiratoria cronica | Malattia cardiopolmonare cronicaStati Uniti, Belgio
-
Zealand University HospitalUniversity of Copenhagen; Technical University of Denmark; OptoCeuticsCompletatoMalattia di AlzheimerDanimarca